[go: up one dir, main page]

MX2013010068A - Ensayos interrogatorios basados en celulas y usos de los mismos. - Google Patents

Ensayos interrogatorios basados en celulas y usos de los mismos.

Info

Publication number
MX2013010068A
MX2013010068A MX2013010068A MX2013010068A MX2013010068A MX 2013010068 A MX2013010068 A MX 2013010068A MX 2013010068 A MX2013010068 A MX 2013010068A MX 2013010068 A MX2013010068 A MX 2013010068A MX 2013010068 A MX2013010068 A MX 2013010068A
Authority
MX
Mexico
Prior art keywords
biological system
data set
model
obtaining
based assays
Prior art date
Application number
MX2013010068A
Other languages
English (en)
Other versions
MX358408B (es
Inventor
Niven Rajin Narain
Rangaprasad Sarangarajan
Vivek K Vishnudas
Original Assignee
Berg Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berg Llc filed Critical Berg Llc
Publication of MX2013010068A publication Critical patent/MX2013010068A/es
Publication of MX358408B publication Critical patent/MX358408B/es

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G16B5/20Probabilistic models
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Genetics & Genomics (AREA)
  • Probability & Statistics with Applications (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

En la presente se describe un Tecnología de Plataforma de descubrimiento para analizar un sistema o proceso biológico (por ejemplo, una enfermedad, tal como cáncer) por medio de un modelo de construcción. En particular, se describe en la presente un método para identificar un modulador de un sistema biológico mediante el establecimiento de un modelo para el sistema biológico, obtener un primer conjunto de datos del modelo para el sistema biológico, obtener un segundo conjunto de datos del modelo para el sistema biológico, y generar una red de relaciones causales de consenso entre los niveles de expresión de la pluralidad de genes y la actividad funcional o la respuesta celular basada únicamente en el primer conjunto de datos y el segundo conjunto de datos, usando un dispositivo informático programado.
MX2013010068A 2011-03-02 2012-03-02 Ensayos interrogatorios basados en celulas y usos de los mismos. MX358408B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161448587P 2011-03-02 2011-03-02
US201261593848P 2012-02-01 2012-02-01
PCT/US2012/027615 WO2012119129A1 (en) 2011-03-02 2012-03-02 Interrogatory cell-based assays and uses thereof

Publications (2)

Publication Number Publication Date
MX2013010068A true MX2013010068A (es) 2013-11-01
MX358408B MX358408B (es) 2018-08-20

Family

ID=46758320

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013010068A MX358408B (es) 2011-03-02 2012-03-02 Ensayos interrogatorios basados en celulas y usos de los mismos.

Country Status (20)

Country Link
US (3) US9886545B2 (es)
EP (1) EP2680925B1 (es)
JP (2) JP6105491B2 (es)
KR (1) KR102071081B1 (es)
CN (2) CN107273712B (es)
AU (2) AU2012223136B2 (es)
BR (1) BR112013022208A2 (es)
CA (1) CA2828972C (es)
CL (2) CL2013002526A1 (es)
CO (1) CO6801640A2 (es)
EA (1) EA201391245A1 (es)
ES (1) ES2777894T3 (es)
IL (2) IL228096B (es)
MX (1) MX358408B (es)
MY (2) MY164530A (es)
PE (2) PE20140627A1 (es)
PH (3) PH12013501802B1 (es)
SG (2) SG193006A1 (es)
WO (1) WO2012119129A1 (es)
ZA (1) ZA201306453B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687239B2 (en) 2003-07-12 2010-03-30 Accelrs Technology Corporation Sensitive and rapid determination of antimicrobial susceptibility
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
ES2551922T3 (es) 2011-03-07 2015-11-24 Accelerate Diagnostics, Inc. Sistemas rápidos de purificación celular
KR20140140069A (ko) * 2012-03-05 2014-12-08 버그 엘엘씨 전반적 발달장애의 진단 및 치료용 조성물 및 그 진단 및 치료 방법
US9744155B2 (en) 2012-03-28 2017-08-29 Ixcela, Inc. IPA as a therapeutic agent, as a protective agent, and as a biomarker of disease risk
AU2012376214B2 (en) 2012-04-02 2019-02-14 Berg Llc Interrogatory cell-based assays and uses thereof
HK1208905A1 (en) 2012-05-22 2016-03-18 Berg Llc Interrogatory cell-based assays for identifying drug-induced toxicity markers
WO2014071316A1 (en) * 2012-11-02 2014-05-08 H. Lee Moffitt Cancer Center And Research Institute, Inc. In silico identification of cancer molecular signaling pathways and drug candidates
WO2014072950A1 (en) * 2012-11-09 2014-05-15 Cellworks Research India Private Limited System and method for development of therapeutic solutions
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
CN105556523B (zh) * 2013-05-28 2017-07-11 凡弗3基因组有限公司 Paradigm药物响应网络
EP3017300A4 (en) * 2013-07-01 2017-03-08 Ixcela, Inc. Systems biology approach to therapy
KR20170028322A (ko) * 2014-05-28 2017-03-13 비토 엔브이 상이한 생물학적 샘플의 혼합물에 포함된 화학적 화합물의 상대적인 정량화 방법
WO2016040725A1 (en) * 2014-09-11 2016-03-17 Berg Llc Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data
CN106716135B (zh) * 2014-10-10 2019-03-15 松森昭 用于检测心力衰竭的装置及储存介质
WO2016094425A1 (en) 2014-12-08 2016-06-16 Berg Llc Use of markers including filamin a in the diagnosis and treatment of prostate cancer
EP3278115A2 (en) 2015-03-30 2018-02-07 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
CN106250717B (zh) * 2015-06-04 2019-03-12 徐勇 急性髓性白血病的miRNA与转录因子的系统及其构建方法和应用
KR101881398B1 (ko) * 2016-04-07 2018-07-24 한국과학기술원 생물학적 시스템 정보 처리 장치 및 방법
AU2017278261A1 (en) 2016-06-05 2019-01-31 Berg Llc Systems and methods for patient stratification and identification of potential biomarkers
US10282588B2 (en) * 2016-06-09 2019-05-07 Siemens Healthcare Gmbh Image-based tumor phenotyping with machine learning from synthetic data
CA3043709A1 (en) 2016-11-14 2018-05-17 Berg Llc Methods for treating parkinson's disease
WO2018094204A1 (en) * 2016-11-17 2018-05-24 Arivale, Inc. Determining relationships between risks for biological conditions and dynamic analytes
WO2018209218A1 (en) * 2017-05-12 2018-11-15 Laboratory Corporation Of America Holdings Compositions and methods for detection of diseases related to exposure to inhaled carcinogens
CN111587293A (zh) 2017-10-02 2020-08-25 皇家飞利浦有限公司 确定免疫细胞类型和免疫应答的功能状态
CN109086570B (zh) * 2018-06-29 2020-09-04 迈凯基因科技有限公司 一种多数据库依次交互方法及装置
EP3814944A4 (en) * 2018-06-29 2022-04-06 The Jackson Laboratory METHOD AND DEVICE FOR IDENTIFICATION OF ALTERNATIVE SPLICING EVENTS
US11041847B1 (en) 2019-01-25 2021-06-22 Ixcela, Inc. Detection and modification of gut microbial population
WO2020180424A1 (en) 2019-03-04 2020-09-10 Iocurrents, Inc. Data compression and communication using machine learning
WO2021005729A1 (ja) * 2019-07-09 2021-01-14 株式会社島津製作所 iPS細胞の分化効率予測モデルの構築方法及びiPS細胞の分化効率予測方法
WO2021050760A1 (en) * 2019-09-11 2021-03-18 Recursion Pharmaceuticals, Inc. Systems and methods for pairwise inference of drug-gene interaction networks
WO2022045334A1 (ja) * 2020-08-31 2022-03-03 武田薬品工業株式会社 推論装置、推論方法、推論プログラム、モデル生成方法、推論サービス提供システム、推論サービス提供方法及び推論サービス提供プログラム
CN112151109B (zh) * 2020-09-09 2023-08-25 中国科学院大连化学物理研究所 用于评价生物分子交联质谱鉴定随机性的半监督学习方法
CN112466403B (zh) * 2020-12-31 2022-06-14 广州基迪奥生物科技有限公司 一种细胞通讯分析方法及系统
KR102556312B1 (ko) 2021-04-12 2023-07-19 서울대학교병원 세뇨관 배양부 및 간질 배양부를 포함하는 신장 모사 장기 칩
US20220399092A1 (en) * 2021-06-10 2022-12-15 Rajant Health Inc. Ai-enabled health platform
CN114038504A (zh) * 2021-11-30 2022-02-11 周建伟 一种识别驱动肿瘤转移关键异质性分子的预测系统
WO2023102204A1 (en) * 2021-12-03 2023-06-08 The Trustees Of Indiana University Biomarker for type 1 diabetes
CN115346687B (zh) * 2022-08-08 2025-07-04 之江实验室 一种采用非线性动态分析辅助神经网络用于评估药物引起的心脏毒性的方法
CN115775594A (zh) * 2022-12-12 2023-03-10 南京医基云医疗数据研究院有限公司 生物组学调控关系分析方法及装置、电子设备、介质
CN116046877B (zh) * 2023-04-03 2024-03-15 深圳先进技术研究院 疾病模型代谢分析方法、包埋模具及喷涂装置
WO2025259359A1 (en) * 2024-06-12 2025-12-18 CytoVale Inc. Systems and methods for sepsis determination

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
EP0247091B1 (en) 1985-11-01 1993-09-29 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
US4868103A (en) 1986-02-19 1989-09-19 Enzo Biochem, Inc. Analyte detection by means of energy transfer
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4902505A (en) 1986-07-30 1990-02-20 Alkermes Chimeric peptides for neuropeptide delivery through the blood-brain barrier
US6121424A (en) 1991-11-25 2000-09-19 Enzon, Inc. Multivalent antigen-binding proteins
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5116742A (en) 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US4904582A (en) 1987-06-11 1990-02-27 Synthetic Genetics Novel amphiphilic nucleic acid conjugates
US4843155A (en) 1987-11-19 1989-06-27 Piotr Chomczynski Product and process for isolating RNA
ATE151110T1 (de) 1988-09-02 1997-04-15 Protein Eng Corp Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5750373A (en) 1990-12-03 1998-05-12 Genentech, Inc. Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
ES2139598T3 (es) 1990-07-10 2000-02-16 Medical Res Council Procedimientos para la produccion de miembros de parejas de union especifica.
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
CA2089661C (en) 1990-08-29 2007-04-03 Nils Lonberg Transgenic non-human animals capable of producing heterologous antibodies
EP1279731B1 (en) 1991-03-01 2007-05-30 Dyax Corporation Process for the development of binding mini-proteins
US5658727A (en) 1991-04-10 1997-08-19 The Scripps Research Institute Heterodimeric receptor libraries using phagemids
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US5621083A (en) 1991-11-04 1997-04-15 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
AU675054B2 (en) 1991-11-22 1997-01-23 Affymetrix, Inc. Combinatorial strategies for polymer synthesis
DE69326967T2 (de) 1992-01-17 2000-06-15 Lakowicz, Joseph R. Phasenmodulationsenergieübertragungsfluoroimmunassay
US5918200A (en) * 1992-08-31 1999-06-29 Yamatake-Honeywell Co., Ltd. State estimating apparatus
DE69433811T2 (de) 1993-01-07 2005-06-23 Sequenom, Inc., San Diego Dns - sequenzierung durch massenspektronomie
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
AU687801B2 (en) 1993-03-19 1998-03-05 Sequenom, Inc. DNA sequencing by mass spectrometry via exonuclease degradation
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
EP0880598A4 (en) 1996-01-23 2005-02-23 Affymetrix Inc RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
US6033860A (en) 1997-10-31 2000-03-07 Affymetrix, Inc. Expression profiles in adult and fetal organs
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
JP2002512203A (ja) * 1998-04-17 2002-04-23 ザ ユニバーシティ オブ バーモント アンド ステイト アグリカルチュラル カレッジ 疾患における代謝的相互作用に関連する方法および製品
US6763307B2 (en) 2000-03-06 2004-07-13 Bioseek, Inc. Patient classification
JP2004533223A (ja) * 2001-03-13 2004-11-04 アッシュニ ナチュラシューティカルズ,インコーポレイティド 生理学的または病態生理学的プロセスに関連するゲノムおよびプロテオーム経路のアソシエーション法
US8000949B2 (en) 2001-06-18 2011-08-16 Genego, Inc. Methods for identification of novel protein drug targets and biomarkers utilizing functional networks
US7393656B2 (en) 2001-07-10 2008-07-01 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for risk stratification
US7415359B2 (en) 2001-11-02 2008-08-19 Gene Network Sciences, Inc. Methods and systems for the identification of components of mammalian biochemical networks as targets for therapeutic agents
AU2002304965A1 (en) 2002-05-24 2003-12-12 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
AU2003270041A1 (en) 2002-08-29 2004-03-19 Gene Network Sciences, Inc. Systems and methods for inferring biological networks
CN1714371A (zh) * 2002-11-19 2005-12-28 Gni美国公司 根据时间序列基因表达数据的基因网络的非线性模拟
JP4288345B2 (ja) 2003-06-19 2009-07-01 独立行政法人産業技術総合研究所 新規てんかんモデル動物
EP1512970A1 (en) 2003-09-05 2005-03-09 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Method for determining the impact of a multicomponent mixture on the biological profile of a disease
WO2005035780A1 (ja) * 2003-10-14 2005-04-21 Cellfree Sciences Co.,Ltd. 指標物質の新規スクリーニング方法
WO2005107412A2 (en) 2004-04-30 2005-11-17 Rosetta Inpharmatics Llc Systems and methods for reconstruction gene networks in segregating populations
EP1607898A3 (en) 2004-05-18 2006-03-29 Neal E. Solomon A bioinformatics system for functional proteomics modelling
US20100316629A1 (en) 2004-09-01 2010-12-16 Shaughnessy Jr John D Use of gene expression profiling to predict survival in cancer patient
JP2008528975A (ja) * 2005-01-24 2008-07-31 ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ 細胞シグナル伝達系のモデリングのためのベイジアンネットワークの使用
JP2008537821A (ja) 2005-03-31 2008-09-25 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 生体分子及び疾患の間の関係に関する証拠を収集するシステム及び方法
JP4051400B2 (ja) 2005-05-31 2008-02-20 株式会社Jclバイオアッセイ プロテオーム網羅的解析における特異的蛋白質のスクリーニング方法
CA2622852A1 (en) 2005-09-30 2007-04-12 Universiteit Maastricht Tumor angiogenesis associated genes and a method for their identification
WO2007086515A1 (ja) * 2006-01-27 2007-08-02 Takeda Pharmaceutical Company Limited 遺伝子発現解析ツール
WO2008060620A2 (en) * 2006-11-15 2008-05-22 Gene Network Sciences, Inc. Systems and methods for modeling and analyzing networks
CN101105841B (zh) * 2007-02-12 2011-06-15 浙江大学 由大规模基因芯片表达谱数据构建基因调控亚网络的方法
US8140270B2 (en) * 2007-03-22 2012-03-20 National Center For Genome Resources Methods and systems for medical sequencing analysis
WO2009020684A1 (en) 2007-05-16 2009-02-12 Edsa Micro Corporation Real-time predictive systems for intelligent energy monitoring and management of electrical power networks
JP2009050171A (ja) 2007-08-23 2009-03-12 Toyobo Co Ltd 表面プラズモン共鳴による基板上におけるリン酸化の検出方法
US7895146B2 (en) * 2007-12-03 2011-02-22 Microsoft Corporation Time modulated generative probabilistic models for automated causal discovery that monitors times of packets
EP3369827B1 (en) * 2008-03-12 2020-12-23 The Rockefeller University Methods and compositions for translational profiling and molecular phenotyping
US8623592B2 (en) 2008-08-15 2014-01-07 Merrimack Pharmaceuticals, Inc. Methods and systems for predicting response of cells to a therapeutic agent
MX2011011958A (es) 2009-05-11 2012-02-13 Berg Biosystems Llc Metodos para el tratamiento de trastornos metabolicos utilizando cambiadores epimetabólicos, moléculas intracelulares multidimensionales o influenciadores ambientales.
EP2600154A4 (en) 2010-03-31 2014-06-11 Univ Kumamoto Nat Univ Corp METHOD FOR GENERATING A DATA SET FOR INTEGRATED PROTEOMICS, METHOD FOR INTEGRATED PROTEOMICS WITH THE DATA PROTEOM FOR INTEGRATED PROTEOMICS PRODUCED IN THIS PRODUCTION PROCESS, AND METHOD FOR IDENTIFYING A DISEASE SUBSTANCE THEREWITH
AU2012376214B2 (en) * 2012-04-02 2019-02-14 Berg Llc Interrogatory cell-based assays and uses thereof
EP3017300A4 (en) * 2013-07-01 2017-03-08 Ixcela, Inc. Systems biology approach to therapy

Also Published As

Publication number Publication date
AU2017202977B2 (en) 2019-09-19
US11456054B2 (en) 2022-09-27
PH12017502073A1 (en) 2019-01-14
AU2017202977A1 (en) 2017-05-25
PE20180776A1 (es) 2018-05-07
US20120258874A1 (en) 2012-10-11
SG193006A1 (en) 2013-10-30
AU2012223136B2 (en) 2017-05-25
ZA201306453B (en) 2021-05-26
IL257824A (en) 2018-04-30
CN103501859A (zh) 2014-01-08
BR112013022208A2 (pt) 2022-03-08
PH12013501802A1 (en) 2013-11-18
IL228096B (en) 2018-03-29
NZ614891A (en) 2016-01-29
CN107273712A (zh) 2017-10-20
CA2828972C (en) 2021-09-07
ES2777894T3 (es) 2020-08-06
NZ712105A (en) 2017-05-26
AU2012223136A1 (en) 2013-09-19
WO2012119129A1 (en) 2012-09-07
JP6105491B2 (ja) 2017-03-29
MY181093A (en) 2020-12-17
US20240062844A1 (en) 2024-02-22
CN103501859B (zh) 2017-08-25
EA201391245A1 (ru) 2014-05-30
JP2017148046A (ja) 2017-08-31
CL2013002526A1 (es) 2014-04-25
EP2680925A4 (en) 2014-12-31
EP2680925B1 (en) 2019-11-20
PH12017502072A1 (en) 2019-01-14
MY164530A (en) 2017-12-29
JP2014512520A (ja) 2014-05-22
EP2680925A1 (en) 2014-01-08
KR102071081B1 (ko) 2020-01-29
PH12013501802B1 (en) 2018-06-27
US9886545B2 (en) 2018-02-06
CN107273712B (zh) 2021-12-03
CO6801640A2 (es) 2013-11-29
CA2828972A1 (en) 2012-09-07
US20180260515A1 (en) 2018-09-13
MX358408B (es) 2018-08-20
KR20140013006A (ko) 2014-02-04
PE20140627A1 (es) 2014-05-30
CL2020002805A1 (es) 2021-04-30
SG10201601224WA (en) 2016-03-30
IL228096A0 (en) 2013-09-30

Similar Documents

Publication Publication Date Title
PH12017502072A1 (en) Interrogatory cell-based assays and uses thereof
Nadachowska-Brzyska et al. Temporal dynamics of avian populations during Pleistocene revealed by whole-genome sequences
WO2013151577A8 (en) Interrogatory cell-based assays and uses thereof
WO2012122549A3 (en) Biological data networks and methods therefor
WO2012024658A3 (en) Integrated analysis system
EA201170472A1 (ru) Реализованные посредством компьютера системы и способы для использования при моделировании геомеханической системы коллектора
NZ594759A (en) A system and method of managing mapping information
EP4462438A3 (en) Population based treatment recommender using cell free dna
EP4495766A3 (en) Systems and methods for performing computer network service chain analytics
EA201391111A1 (ru) Система и способ для использования искусственной нейронной сети для моделирования гидравлики трубопроводов в имитаторе пластов
SG10201407638RA (en) Small plasma chamber systems and methods
BR112012006055A2 (pt) métodos para uso na previsão de produção de areia de um sistema de reservatório geomecânico, para produção de areia de um sistema de reservatório geomecânico, e, para operar um sistema de reservatório geomecânico para controlar produção de areia do sistema de reservatório geomecânico
WO2009002949A3 (en) System, method and apparatus for predictive modeling of specially distributed data for location based commercial services
WO2012116309A3 (en) System, method & computer program product for constructing an optimized factor portfolio
MY164162A (en) System validation
BR112014027592A2 (pt) método para prover uma interface de rastreamento médico para comunicação entre pelo menos uma ferramenta de rastreamento de intervenção e um aplicativo de intervenção orientada por imagem (igi), interface de rastreamento médico, e produto de programa de computador
BRPI0901425A2 (pt) método para análise de desempenho de um sistema de desenvolvimento de jazida, sistema para análise de desempenho de um sistema de desenvolvimento de jazida, produto de programa de computador para análise de desempenho de um sistema de desenvolvimento de jazida, método de provisão de um sistema para análise de desempenho de um sistema de desenvolvimento de jazida, e método para realização de uma análise de equiparação de curva de tipo de uma resposta de comportamento térmico transiente de um sistema de deselvolvimento de jazida
ATE398808T1 (de) Systeme und verfahren zum schliessen auf biologische netzwerke
GB201312383D0 (en) Network system, network apparatus, and network information setting method
Gallo et al. Ion currents involved in gamete physiology.
FI20115857A0 (fi) Älykäs kapasiteetin hallinta
WO2007005931A3 (en) Method and apparatus for integrated modeling, simulation and analysis of chemical and biological systems having a sequence of reactions, each simulated at a reaction time determined based on reaction kinetics
MX2019002316A (es) Sistemas, metodos y perfiles geneticos para predecir un estado biologico de un individuo.
WO2008051660A3 (en) Apparatus and method for computer modeling chemical sensitivity of skin
Kamyshnyi et al. Forecasting Influenza Epidemics and Pandemics in the Age of AI and Machine Learning

Legal Events

Date Code Title Description
FG Grant or registration